Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

344 ARTÍCULOS , VIENDO DEL 241 AL 255

Treatment of Pantothenate-Kinase Neurodegeneration With Baclofen, Botulinum Toxin, and Deferiprone: A Case Report

Hameed M, Siddiqui F, Khan MK, Tadisetty S, Gangishetti PK.

Brain Neurorehabil. 2023 Sep 25;16(3):e25. doi: 10.12786/bn.2023.16.e25. eCollection 2023 Nov.

Brief pump externalization without ITB wean to treat a probable pocket infection

Strader S, Mutchnick I.

Childs Nerv Syst. 2023 Dec;39(12):3643-3645. doi: 10.1007/s00381-023-06075-z. Epub 2023 Jul 17.

Novel TLR7 hemizygous variant in post-COVID-19 neurological deterioration: a case report with literature review

Noor Eddin A, Al-Rimawi M, Peer-Zada F, Hundallah K, Alhashem A.

Front Neurol. 2023 Nov 29;14:1268035. doi: 10.3389/fneur.2023.1268035. eCollection 2023.

Selective Dorsal Rhizotomy For Treatment of Spasticity After Hemispherectomy In Children: A Case Report

Park TS, Joh S, Smyth MD, Meyer NL, Walter DM.

Cureus. 2023 Mar 31;15(3):e36945. doi: 10.7759/cureus.36945. eCollection 2023 Mar.

Treatment of adult spasticity with Botox (onabotulinumtoxinA): Development, insights, and impact

Esquenazi A, Jost WH, Turkel CC, Wein T, Dimitrova R.

Medicine (Baltimore). 2023 Jul 1;102(S1):e32376. doi: 10.1097/MD.0000000000032376.

A Case of Tardive Dystonia with Task Specificity Confined to the Lower Extremities only during Walking

Hatori K, Tagawa Y, Hatano T, Akiyama O, Izawa N, Kondo A, Sato K, Watanabe A, Hattori N, Fujiwara T.

Prog Rehabil Med. 2023 May 12;8:20230014. doi: 10.2490/prm.20230014. eCollection 2023.

A multicenter initiative to reduce intrathecal baclofen pump surgical site infection: a Cerebral Palsy Research Network quality improvement project

Bollo RJ, Gross PH, Rocque BG, Browd SR, Raskin JS, Leonard JR, Albarqawi L, Bailes AF; Cerebral Palsy Research Network (CPRN).

J Neurosurg Pediatr. 2023 Feb 24;31(5):444-452. doi: 10.3171/2023.1.PEDS22368. Print 2023 May 1.

Exploring the Central Mechanisms of Botulinum Toxin in Parkinson's Disease: A Systematic Review from Animal Models to Human Evidence

Cutrona C, Marchet F, Costanzo M, De Bartolo MI, Leodori G, Ferrazzano G, Conte A, Fabbrini G, Berardelli A, Belvisi D.

Toxins (Basel). 2023 Dec 23;16(1):9. doi: 10.3390/toxins16010009.

YIF1B-related Kaya-Barakat-Masson Syndrome: Report of a new patient and literature review

Sanri A, Mutlu MB, Sezer O.

Eur J Med Genet. 2023 Jun;66(6):104751. doi: 10.1016/j.ejmg.2023.104751. Epub 2023 Mar 21.

Overview of Cochrane systematic reviews for rehabilitation interventions in individuals with cerebral palsy: A mapping synthesis

Liguori S, Young VM, Arienti C, Pollini E, Patrini M, Gimigliano F, Negrini S, Kiekens C.

Dev Med Child Neurol. 2023 Oct;65(10):1280-1291. doi: 10.1111/dmcn.15572. Epub 2023 Mar 12.

Botulinum toxin A and neuropathic pain: An update

Spagna A, Attal N.

Toxicon. 2023 Aug 15;232:107208. doi: 10.1016/j.toxicon.2023.107208. Epub 2023 Jun 27.

Establishing Patient-Centered Outcomes for MCT8 Deficiency: Stakeholder Engagement and Systematic Literature Review

Wilpert NM, Tonduti D, Vaia Y, Krude H, Sarret C, Schuelke M.

Neuropsychiatr Dis Treat. 2023 Oct 20;19:2195-2216. doi: 10.2147/NDT.S379703. eCollection 2023.

Neurosurgical management of elevated tone in childhood: interventions, indications and uncertainties

Lumsden DE.

Arch Dis Child. 2023 Sep;108(9):703-708. doi: 10.1136/archdischild-2020-320907. Epub 2023 Jan 23.

The pluripotential evolution and journey of Botox (onabotulinumtoxinA)

Brin MF, Blitzer A.

Medicine (Baltimore). 2023 Jul 1;102(S1):e32373. doi: 10.1097/MD.0000000000032373.

Botulinum toxin for motor disorders

Safarpour D, Jabbari B.

Handb Clin Neurol. 2023;196:539-555. doi: 10.1016/B978-0-323-98817-9.00003-X.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias